MEDIUM confidence: 100% data completeness, but the composite (57) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net insider -$183.9M over 180 days (0 open-market buys, 8 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $10.9B— | $12.6B+16.1% | $12.6B-0.5% | $15.2B+21.3% | $23.1B+51.7% |
| EPS (dil.) | $0.64— | $0.77+20.5% | $0.78+2.0% | $0.96+23.1% | $1.67+74.0% |
| Free Cash Flow | $1.2B— | $1.8B+51.8% | $2.2B+20.4% | $2.1B-0.3% | $4.4B+103.7% |
| Gross Margin | 31.3% | 31.9%+0.6pp | 32.5%+0.6pp | 33.8%+1.2pp | 37.2%+3.5pp |
| Operating Margin | 20.0% | 20.7%+0.7pp | 20.7%+0.0pp | 21.6%+0.9pp | 25.4%+3.8pp |
| Net Margin | 14.6% | 15.1%+0.4pp | 15.4%+0.3pp | 15.9%+0.6pp | 18.5%+2.6pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $103 (last qtr, 6 analysts) → $105 (last mo, 4) (+1.9%).
Buy-rated share 83% → 89% over ~3 months (+6pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $0.73 | $0.80 | +9.7% |
| Jul 2026 | $0.59 | $0.68 | +15.3% |
| Apr 2026 | $0.95 | $1.06 | +11.6% |
| Jan 2026 | $0.47 | $0.97 | +107.9% |
| Oct 2025 | $0.40 | $0.51 | +28.6% |
| Jul 2025 | $0.33 | $0.41 | +21.5% |
| Apr 2025 | $0.26 | $0.32 | +20.6% |
| Jan 2025 | $0.25 | $0.55 | +119.2% |
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 10.7%/yr (revenue basis).
Base free cash flow $2.9B (avg FY2023–FY2025; latest year $4.4B) · equity value $191.8B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 57 for Amphenol Corporation suggests a neutral outlook, with the stock's strengths and weaknesses balancing out. The company scores high on growth, driven by impressive revenue and earnings growth of 51.7% and 74.6%, respectively. However, it trades at a premium, with a P/E of 32.3, which brings down its value score, while its momentum is moderate, exhibiting a 12-month return of 11.4% and a recent 3-month decline of 4.7%. The long-term and short-term scores are closely aligned, indicating a consistent view of the stock's prospects.